drugset / Trial / NCT02714049
Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
Unblinded study of flibanserin for 8 weeks with responders randomized 1:1 to receive study medication alone vs. study medication and sex therapy for 12 additional weeks.
Timeline
- Start
- 2017-01-25
- Primary completion
- 2019-01-18
- Completion
- 2019-01-30
Outcome
Outcome not reported
Stopped: “Investor Initiated Grant support stopped when drug was sold.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | flibanserin | Small molecule | — | — |